U.S. regulators on Friday delayed a decision on whether to approve over-the-counter sales of a Barr Pharmaceuticals "morning-after pill" to prevent pregnancy, prompting a lawsuit from a women's rights group.
more...
A "morning after" treatment for the AIDS virus can help prevent infection after a rape, contact with a contaminated needle or even a night of passion without a condom, U.S. health officials said on Thursday.
more...
More evidence of how painkillers called COX-2 inhibitors can raise the risk of heart disease was published Monday, showing Pfizer Inc.'s Bextra can triple the risk of heart attack and stroke in certain patients.
more...
Women's rights groups seeking easier access to emergency contraception are pressuring U.S. regulators as they try to decide whether to approve a non-prescription "morning-after" pill.
more...
A U.S. advisory panel on Friday urged regulators to reject over-the-counter sales of Merck & Co. Inc.'s cholesterol-lowering drug Mevacor because of doubts the medicine could be used safely without a doctor's guidance.
more...
Contrary to some past reports, new study findings indicate that women who douche do not increase their risk of pelvic inflammatory disease, or genital infections such as gonorrhea or chlamydia.
more...
An increasingly popular prostate cancer treatment also makes bones brittle and may be responsible for over 3,000 fractures each year in the United States, researchers reported on Wednesday.
more...